Market Overview

Canaccord Genuity Initiates Coverage on Biogen Idec Inc. at Hold, Announces $144.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for BIIB

DateFirmActionFromTo
Aug 2016Morgan StanleyMaintainsOverweight
Aug 2016Standpoint ResearchDowngradesBuyHold
Aug 2016Raymond JamesMaintainsStrong Buy

View More Analyst Ratings for BIIB
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (BIIB)